HumanFirst Offers Access to Industry's Largest Decentralized Clinical Trial Database

With 2000+ Digital Health Technologies covering 800+ medical conditions, researchers in academia, pharma and biotech are benefiting from access to the most comprehensive platform for digital measures and connected technologies.

SAN FRANCISCO, Oct. 4, 2022 /PRNewswire/ -- HumanFirst, a software company advancing the safe and effective use of digital health technologies at home, today announced the launch of two new versions of the Atlas platform designed specifically for researchers in industry (AtlasPro) and academia (AtlasEDU).

Atlas was created by HumanFirst to unlock better research for all humans sooner, and has been used for planning and deployment of trustworthy hybrid and at-home clinical trials by 22 of the 25 largest pharmaceutical companies and 23 of the top 50 academic institutions in the world.

AtlasPro includes workflow and infrastructure solutions that give leading pharma and biotech companies access to the most up-to-date, streamlined research across over 10,000 digital measures.

"Every day that a drug is not on the market, pharmaceutical companies can lose an average of $3M. We created AtlasPro to move the industry forward, increasing trial speed, accessibility and accuracy while helping to save millions of dollars in the process," explains Andy Coravos, CEO and founder of HumanFirst.

AtlasEDU is a free, full-featured version of the tlas platform customized specifically for academic researchers who qualify.

"We've long recognized the benefit Atlas could bring to academic researchers in advancing the use of digital health technologies, and we've spent the past several months advancing our algorithms and curation processes so we could support meaningful academic research at no cost to the investigators who move critical medical advancements forward every day," says Manny Fanarjian, Head of Applied Sciences at HumanFirst.

Dr. Jessilyn Dunn, Assistant Professor and Principal Investigator at Duke, is one such researcher. Dr. Dunn leads the Duke Big Ideas Lab and the COVIDENTIFY study, designed to detect COVID-19 using wearable technologies. "Access to AtlasEDU will have a tremendous impact in speeding up research, and ensuring we're using the best-fit technologies for capturing digital measures," explains Dunn. "I'm thrilled that academic researchers can now benefit from expanded access to such a comprehensive database."

Industry researchers interested in AtlasPro can get in touch with our team <here>. Academic researchers and clinicians interested in free use of AtlasEDU can fill out a short, 5-minute form to see if they qualify at <link>.

HumanFirst offers workflow and infrastructure solutions that help leading organizations plan for and deploy effective hybrid and at-home clinical trials and research. 22 of the 25 largest pharmaceutical companies in the world and several leading research universities have used the HumanFirst platform to prepare for, execute and analyze deployment of Digital Health Technologies (DHTs) since the company's 2019 launch. HumanFirst is hiring! For more information, please visit gohumanfirst.com or follow HumanFirst on Twitter, LinkedIn, Medium and Facebook.

Media Contact:
Lauren Davis
+1 (512) 751-2946

View original content to download multimedia:https://www.prnewswire.com/news-releases/humanfirst-offers-access-to-industrys-largest-decentralized-clinical-trial-database-301639990.html

SOURCE HumanFirst

[ Back To TMCnet.com's Homepage ]